Skip to content

Crestline Management, L.P.

Follow

13F filer, CIK 1536054, FORT WORTH, TX

Crestline Management, L.P. reported $46,267,385 across 3 holdings for the quarter ended 2026-03-31, in a 13F-HR/A filed 2026-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001315863-26-000422

Period
2026-03-31
Reported value
$46.3M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
EGHTadded+270$448

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DNLIreduced-600,000-$11.5M
SANAreduced-465,201-$1.34M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR/A 0001315863-26-000422, largest first. % of portfolio is the value over $46,267,385, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,460,732 shares; 2024Q4: 4,310,732 shares; 2025Q1: 4,160,732 shares; 2025Q2: 3,860,732 shares; 2025Q3: 3,410,732 shares; 2025Q4: 2,810,732 shares; 2026Q1: 2,210,732 shares 2,210,732$42.4M91.74%-600,000Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,085,624 shares; 2024Q4: 2,860,937 shares; 2025Q1: 2,790,937 shares; 2025Q2: 2,420,937 shares; 2025Q3: 1,820,937 shares; 2025Q4: 1,220,937 shares; 2026Q1: 755,736 shares 755,736$2.18M4.7%-465,201Timeline
EGHT8X8 INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 998,380 shares; 2024Q4: 998,380 shares; 2025Q1: 990,580 shares; 2025Q2: 990,580 shares; 2025Q3: 990,580 shares; 2025Q4: 990,580 shares; 2026Q1: 990,850 shares 990,850$1.64M3.56%+270Timeline

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001315863-26-000412 superseded2026-05-15acceptance time not in the bulk data set
13F-HR/A 0001315863-26-000422 baserestatement2026-05-15acceptance time not in the bulk data set